Navigation Links
Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges Is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market
Date:12/3/2013

DUBLIN, December 3, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/67g6vc/global) has announced the addition of the "Global Genitourinary Drugs Market 2011-2015" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel biological drugs. The Global Genitourinary Drugs market has also been witnessing a paradigm shift toward biological drugs. However, lack of adherence to medication could pose a challenge to the growth of this market.

The key vendors dominating this space are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Eli Lilly and Co., GlaxoSmithKline plc, Merck and Co. Inc., and Pfizer Inc.

Other vendors mentioned in the report are Agile Therapeutics Inc., Allergan Inc., Antares Pharma Inc., Boehringer Ingelheim GmbH, Dong-A Pharmaceutical Co. Ltd., Detrol LA, Ferring Holding S.A., Kissei Pharmaceutical Co. Ltd., Merck Serono S.A., Novartis International AG, Novo Nordisk A/S, Nymox Pharmaceutical Corp., PregLem S.A., Recordati S.p.A., Rottapharm S.p.A., Teva Pharmaceutical Industries Ltd., VIVUS Inc., Warner Chilcott plc, and Watson Pharmaceuticals Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said: "Patients suffering from infections and disorders related to genitourinary systems are using steroids and immunosuppressants. However, these medications cause serious side effects because they are chemically synthesized. Hence, patients are turning to biological drugs that not only cau
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Xlumena Closes Series C Financing; Focuses on Expanding Global Commercial Presence and Obtaining FDA Clearance
2. Bone Densitometers Market is Expected to Reach USD 908.5 Million Globally in 2019: Transparency Market Research
3. The Global Fund Replenishment Partners Talk Shared Responsibility
4. Spectrometers And Spectrophoto/Fluorometers - 2012 Global Strategic Business Report with Forecasts to 2018
5. Global Urological Catheters (Dialysis & Urinary) Strategic Business Report 2013-2018: Urinary Catheters Take the Lead
6. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
7. Natural Source Vitamin E (Tocopherols and Tocotrienols) - A Global Market Overview
8. InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
9. NineSigma, GE Announce Selection of 10 Finalists in GE Global 3D Printing Production Quest
10. Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
11. Global Electronics Market 2018 Forecasts for 6 Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... ROCHESTER, Minn. , March 4, 2015   ... reached an agreement to develop the next generation of ... "We are hoping that this technology will be ... obesity and diabetes," says James Levine, M.D., Ph.D. ... researcher. "They are accurate, inexpensive, and can be integrated ...
(Date:3/4/2015)... PHILADELPHIA , March 4, 2015 ... be attending the 2015 Distribution Management Conference and ... This conference is HDMA,s largest supply chain education ... and third parties who keep the pharmaceutical distribution ... spotlight on regulatory and legislative issues important to ...
(Date:3/4/2015)... March 4, 2015 Following the reintroduction ... Action Center (LAC) released a report today urging ... opioid and heroin epidemic through more effective use ... report, "The Case for Expanding Access to Medication-Assisted ... outlines the health, justice, and economic advantages of ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2
... , March 11 Watson Pharmaceuticals, Inc. ... Food and Drug Administration (FDA) approval of TRELSTAR® 22.5 ... formulation of TRELSTAR®, a proven, simple and effective palliative ... launch, TRELSTAR® 22.5 mg is the first and only ...
... SiteJabber.com , a leading consumer protection service which helps people avoid fraudulent websites and find good sites, and LegitScript.com ... websites and avoid fraudulent ones. , ... ... ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 2SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 3
(Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
(Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The New ... and lyrical music, will be performed by the award-winning ... Estates, CA, this March 6-22, 2015, on Fridays, Saturdays ... at Peninsula High School (27118 Silver Spur Road, ... hour before the program or may be purchased on-line ...
(Date:3/4/2015)... 2015 The report covers spices ... marketing channels, industry development trend and proposals. The ... including spices definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3
... Speaker Nancy Pelosi issued the following statement today ... Prevention and Tobacco Control Act, which gives the Food ... and marketing. , , "Today, President Obama ... making America healthier. This bipartisan legislation grants the FDA ...
... Park Targets Pittsburgh Children ... United Concordia Dental and the Pittsburgh Pirates organization began several years ago, ... community as Pennsylvanians and the nation struggle with the uncertainty of a ... will team up from 4 to 7 p.m. Monday June 29 at ...
... disorder marked in part by auditory hallucinations and paranoia, can ... when people are ready to stand on their own two ... scientists at UCLA think they are beginning to understand one ... its kind, the researchers used a novel form of brain ...
... MARINO, Calif., June 22 Epeius Biotechnologies ( ... with a dramatic demonstration of single-agent efficacy with its ... (accessible online as of June 16, 2009 in Molecular ... Gene Therapy, www.nature.com/mt/ ) documents the ...
... Washington, D.C.-based law firm of Schmidt & Clark, LLP ... the U.S. Food and Drug Administration where ... Inc. (NYSE: ABT ) failed to disclose multiple reports ... , , In an Associated Press story reported June 20, ...
... , HARBIN, China, June 22 ... Medical" or "the Company") (Nasdaq: CSKI ), ... People,s Republic of China ("PRC"), today announced that it,obtained ... proprietary Sumei,Slim Patch from Heilongjiang Provincial FDA, which will ...
Cached Medicine News:Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 2Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 3Health News:Alterations in brain's white matter key to schizophrenia, UCLA study shows 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 3
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: